Program Description: Transform Your Approach to MASLD – Metabolic Dysfunction Associated Steatotic Liver Disease – one of the most underdiagnosed conditions in obesity care. With up to half of cases going undetected, MASLD is often overlooked, but this on demand webcast will empower you to identify it sooner and care for patients more effectively.

Target Audience: This educational program is designed for Endocrinologists, Hepatologists, Primary Care Physicians (MDs and DOs), and Advanced Practice Providers (e.g., Nurse Practitioners (NPs) and Physician Associates (PAs) working in specialty or primary care clinics. A secondary audience includes Pharmacists and other allied health professionals.

By completing this on demand webcast, participants can expect to learn how to:

• Analyze the natural history and clinical consequences of MASLD to differentiate disease stages and describe outcomes.
• Evaluate and apply two evidence-based strategies to improve the detection of MASLD, MASH, and hepatic fibrosis;
• Identify and articulate the pathophysiologic mechanisms that underlie the development and progression of MASLD; and
• Critically appraise and synthesize safety and efficacy findings from recent clinical trials of dual GLP-1/glucagon receptor agonists for MASH treatment.